Jack Lau

is sleeping

[Celine Chui HKU @ChuiCeline]

P-CARDIAC is highly receptive among clinicians and patients. It shows promise in monitoring cardiovascular health and feasibility in implementing in primary care. #AIHealth #cardiology @NatalieTsie @ChunKaWong @hkumed @hku_son @HkuPharm

https://t.co/SGLV8P5DFF

[Celine Chui HKU @ChuiCeline]

Our study on repeated antibiotic prescribing in patients living with dementia. While we found no association with seizure or other neuropsychiatric disorders, repeated antibiotic courses were associated with an increased risk of all-cause hospitalization. https://t.co/MfxoeSOmok

[Jack Lau @jackilau]

@WaikiCheung1 @QiuyanYu_ @PengWuPengWu Shuk-ching Wong, Dr Vincent Cheng @ElizaTYT @IvanHung2 @Prof_IanWong @catmoore_1 Tsz Kin Khan, Isaya Sukarom, Kim Shijian Lao

[Jack Lau @jackilau]

Happy to share our study on Pneumococcal disease epidemiology on International Journal of Infectious Diseases:
Children and adolescents had an elevated risk of gaining antimicrobial resistance, suggesting more measures to reduce S. pneumoniae infections

https://t.co/x0pvnqkL2q

[Franco WT Cheng @kfranco_c]

Our new study is out! We looked at anaemia treatments (ESAs) and fracture risk in CKD patients.

Prolonged ESA use seems linked to a higher risk of osteoporotic fractures. This suggests we need to optimise treatment to balance benefits vs. risk. Full text: https://t.co/h3GtofA46m

[Min Fan @fm_fanmin]

Our modified self-controlled case series (https://t.co/ovfmS22Lul) did not identify an increased #ischemic_stroke risk with #PPI_monotherapy. However, co-prescription with #antithrombotics was associated with a higher risk. Careful monitoring is needed for them.
@ChuiCeline

[Jack Lau @jackilau]

@CSMPR_HKUPharm @ChuiCeline

[Luna Wei Yue @WeiYLuna]

Excited to share our latest study in @TheLancet: long-acting injectable antipsychotics (LAIAs) are more effective than oral and equally safe for older people, except for higher risk of EPS with typical LAIAs, but not with atypical LAIAs. @Esther_CSMPRHKU
https://t.co/xQB0YitlVz

[Callie Caige Huang @Callie_Huang123]

Excited to share our latest study in @LancetRH_WPac : Psychotropic medication consumption increased globally after the onset of the COVID-19 pandemic, with variations in consumption patterns observed across different countries. @Esther_CSMPRHKU
https://t.co/umLRvID1Tl

[Edmund Cheung @edmundccheung]

Our multinational database study in @eClinicalMed
compared antihypertensive prescribing trends in Hong Kong, United Kingdom, Sweden, and Australia, providing evidence on the use of blood pressure-lowering drugs before and after a diagnosis of dementia.
https://t.co/CDKZL0dcQq

[Prof Ian Wong @Prof_IanWong]

Read our paper on 18 Countries and HK Opioid Prescribing Trend from 2001 to 2019. Very big differences between countries and US is going down.

https://t.co/8ky28wjo6C

[Celine Chui HKU @ChuiCeline]

Duramax, a reinforcement learning framework designed to optimize long-term lipid-modifying therapy for CVD prevention. It helps bridge the gap between AI-driven precision and real-world clinical utility.

https://t.co/oLYZVsrj3a

[Kyung Jin (Jin) Lee @KyungJinLee19]

Our latest longitudinal study on trends in #benzodiazepines and #Z-drug prescribing in Hong Kong has just been published with @ElsevierConnect in @LancetRH_WPac. We found increasing trends from 2014 to 2023, with a notable increase in young adults. @Esther_CSMPRHKU

[Hao Luo @HaoLuo_UW]

Our latest multinational study on trends in survival after #Dementia diagnosis has just been published with @SpringerNature in @CommsMedicine
Read here: https://t.co/B1LWgZI8Cf
@Ian_HKU @ChuiCeline @KennethKCMan @Knappem @GloW_hk

[Celine Chui HKU @ChuiCeline]

Our study, the largest conducted to date examining various classes of antihypertensive drugs and dementia risk. We found a lower risk of all-cause dementia with ARBs compared to ACE inhibitors. Hong Kong, UK, Sweden, and Australia data included.
https://t.co/GJajp4h6uK

[Prof Ian Wong @Prof_IanWong]

Our study reveals persistently elevated rates of psychotropic drug prescriptions beyond the initial phase of the pandemic among patients with depression and anxiety in the post-pandemic era. The Lancet Psychiatry https://t.co/YGohE2iZ6H

[Jack Lau @jackilau]

https://t.co/fWOS7KJDWf